Keyphrases
Anticoagulant Therapy
22%
Bleeding
44%
Cancer Patients
100%
Confidence Interval
55%
Deep Vein Thrombosis
11%
Enfermedad
11%
Heparin Therapy
22%
High Mortality Rate
11%
In Cancer
100%
Low Molecular Weight Heparin
100%
Major Bleeding
33%
Matched Cohort Study
11%
Non-majors
22%
Propensity Matching
11%
Propensity Score Matching
11%
Pulmonary Embolism
11%
Recurrent Deep Vein Thrombosis
11%
Recurrent Pulmonary Embolism
11%
Recurrent Venous Thromboembolism
11%
Relative Risk
55%
Stent Thrombosis
11%
Therapy Switch
11%
Thrombosis Recurrence
33%
Treatment Choice
11%
Venous Thromboembolism
100%
Venous Thrombosis
22%
Vitamin K Antagonists
100%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
22%
Antivitamin K
100%
Bleeding
44%
Cohort Study
11%
Deep Vein Thrombosis
22%
Embolism
11%
Low Molecular Weight Heparin
100%
Lung Embolism
22%
Malignant Neoplasm
100%
Mortality Rate
11%
Recurrent Disease
44%
Vein Thrombosis
33%
Venous Thromboembolism
100%
Nursing and Health Professions
Anticoagulant Therapy
22%
Antivitamin K
100%
Bleeding
44%
Cohort Analysis
11%
Confidence Interval
55%
Deep Vein Thrombosis
22%
Embolism
11%
Heparinization
11%
Low Molecular Weight Heparin
100%
Lung Embolism
22%
Malignant Neoplasm
11%
Mortality Rate
11%
Propensity Score
11%
Recurrent Disease
44%
Vein Thrombosis
33%
Venous Thromboembolism
100%
Medicine and Dentistry
Anticoagulant Therapy
22%
Bleeding
22%
Cohort Analysis
11%
Deep Vein Thrombosis
22%
Embolism
11%
Heparinization
11%
Low Molecular Weight Heparin
100%
Major Bleeding
33%
Malignant Neoplasm
11%
Mortality Rate
11%
Phlebothrombosis
33%
Pulmonary Embolism
22%
Recurrent Disease
44%
Venous Thromboembolism
100%
Vitamin K Antagonist
100%